The viscosity of biofluids such as blood and saliva can reflect an individual’s health conditions, and viscosity measurements are therefore considered in health monitoring and disease diagnosis. However, conventional viscometers can only handle a larger liquid volume beyond the quantity that can be extracted from a person. Though very effective, micro-sensors based on electrokinetic, ultrasonic, or other principles often have strict requirements for the supporting equipment and complicated procedures and signal processing. Sample contamination is always an important issue. In this paper, we report a microfluidic viscometer requiring a small volume of biosamples (<50 µl) and straightforward operation procedures. It is fabricated with low-cost and biocompatible polymeric materials as one-time-use devices, such that contamination is no longer the concern. It contains a suspending micromembrane located along a microchannel. Under a steady driving pressure, the membrane displacement is a function of viscosity of the liquid sample being tested. We derived a simple analytical relation and perform a simulation for converting the membrane displacement to the sample viscosity. We conducted experiments with liquids (water and mineral oil) with defined properties to verify such a relation. We further applied the micro-viscometer to measure bovine blood samples with different hematocrit levels. It can be concluded that the microfluidic viscometer has a high compatibility with a broad range of biomedical applications.

Immunoassay for detailed analysis of immune−cancer intercellular interactions can achieve more promising diagnosis and treatment strategies for cancers including nasopharyngeal cancer (NPC). In this study, we report a microfluidic live−cell immunoassay integrated with a microtopographic environment to meet the rising demand for monitoring intercellular interactions in different tumor microenvironments. The developed assay allows: (1) coculture of immune cells and cancer cells on tunable (flat or micrograting) substrates, (2) simultaneous detection of different cytokines in a wide working range of 5–5000 pg/mL, and (3) investigation of migration behaviors of mono- and co-cultured cells on flat/grating platforms for revealing the topography-induced intercellular and cytokine responses. Cytokine monitoring was achieved on-chip by implementing a sensitive and selective microbead-based sandwich assay with an antibody on microbeads, target cytokines, and the matching fluorescent-conjugated detection antibody in an array of active peristaltic mixer-assisted cytokine detection microchambers. Moreover, this immunoassay requires a low sample volume down to 0.5 μL and short assay time (30 min) for on-chip cytokine quantifications. We validated the biocompatibility of the co-culture strategy between immune cells and NPC cells and compared the different immunological states of undifferentiated THP-1 monocytic cells or PMA-differentiated THP-1 macrophages co-culturing with NP460 and NPC43 on topographical and planar substrates, respectively. Hence, the integrated microfluidic platform provides an efficient, broad-range and precise on-chip cytokine detection approach, eliminates the manual sampling procedures and allows on-chip continuous cytokine monitoring without perturbing intercellular microenvironments on different topographical ECM substrates, which has the potential of providing clinical significance in early immune diagnosis, personalized immunotherapy, and precision medicine.